Clinical Value of Platelet Associated Antibodies in Evaluating the Therapeutic Effect on Children with Immune Thrombocytopenia
Objective:To investigate the clinical value of platelet associated antibodies(PA-Ig)in e-valuating the therapeutic effect on children with immune thrombocytopenia(ITP).Methods:A study from February 2020 to February 2023 was conducted.104 children with ITP(observation group)and 22 healthy children(control group)were selected as the study subjects.Children in the observation group were divided into the complete response group,the effective group,and the ineffective group based on the treatment out-comes.All children were tested for PA-Ig levels.Results:Among the 104 children in the observation group,85(81.73%)achieved complete response(complete response group),11(10.58%)showed effectiveness(effective group),and the remaining 8(7.69%)were ineffective(ineffective group).PA-IgG,PA-IgM,and PA-IgA levels in the observation group were lower than those in the control group(P<0.05).In the complete response group,PA-IgG,PA-IgM,and PA-IgA levels were lower than in the effective and ineffec-tive groups.The effective group had lower levels compared to the ineffective group.There were statistically significant differences in PA-IgG,PA-IgM,and PA-IgA levels among the three groups with different treat-ment outcomes(P<0.05).Conclusion:Testing PA-Ig levels in pediatric ITP patients is beneficial for tailor-ing treatment and assessing early efficacy,reducing the risk of treatment,and has certain value in the evalua-tion of treatment outcomes in pediatric ITP patients.
国家科技期刊平台
NSTL
万方数据
维普
